Gammagard Liquid(immunoglobulin G, human)
Dosage & Administration
PI: Intravenous (IV)
Dose | Initial Infusion Rate | Maintenance Infusion Rate |
---|---|---|
300 to 600 milligram (mg)/kg every 3 to 4 weeks based on clinical response | 0.5milliliter (mL)/kg/hr (0.8 mg/kg/min) for 30 minutes | Increase every 30minutes (if tolerated) up to 5 mL/kg/hr (8 mg/kg/min) |
Subcutaneous (SC)
Dose | Initial Infusion Rate | Maintenance Infusion Rate |
---|---|---|
Initial Dose is 1.37 × previous intravenous dose divided by # of weeks between intravenous doses. Maintenance dose is based on clinical response and target IgG trough level. | 40 kg BW and greater: 30 mL/site at 20 mL/hr/site Under 40 kg BW: 20 mL/site at 15 mL/hr/site | 40 kg BW and greater: 30 mL/site at 20 to 30 mL/hr/site Under 40 kg BW: 20 mL/site at 15 to 20 mL/hr/site |
MMN: Intravenous (IV)
Dose | Initial Infusion Rate | Maintenance Infusion Rate |
---|---|---|
Dose range 0.5 to 2.4 gram/kg/month based on clinical response | 0.5mL/kg/hr (0.8 mg/kg/min) | Infusion rate may be advanced if tolerated to 5.4 mL/kg/hr (9 mg/kg/min) |
CIDP: Intravenous (IV)
Dose | Initial Infusion Rate | Maintenance Infusion Rate |
---|---|---|
Induction dose is 2 g/kg in divided doses over 2 to 5 consecutive days, followed by maintenance infusions. Maintenance dose is 1 g/kg in divided doses over 1 to 4 consecutive days, every 3 weeks. | 0.5 mL/kg/hr (0.8 mg/kg/min) | Infusion rate may be increased if tolerated up to 5.4 mL/kg/hr (9 mg/kg/min) |
Gammagard Liquid Prescribing Information
Gammagard Liquid Prior Authorization Resources
Most recent state uniform prior authorization forms
Verified: Oct 24, 2024Arizona - Uniform Prior Authorization Form
Verified: Oct 24, 2024Colorado - Uniform Prior Authorization Form
Verified: Oct 24, 2024Hawaii - Uniform Prior Authorization Form
Verified: Oct 24, 2024Illinois - Uniform Prior Authorization Form
Verified: Oct 24, 2024Indiana - Uniform Prior Authorization Form
Verified: Oct 24, 2024Louisiana - Uniform Prior Authorization Form
Verified: Oct 24, 2024Minnesota - Uniform Prior Authorization Form
Verified: Oct 24, 2024New Hampshire - Uniform Prior Authorization Form
Verified: Oct 24, 2024New Mexico - Uniform Prior Authorization Form
Verified: Oct 24, 2024Oregon - Uniform Prior Authorization Form
Verified: Oct 24, 2024Texas - Uniform Prior Authorization Form
Verified: Oct 05, 2024Washington - Uniform Prior Authorization Form
Verified: Oct 05, 2024Wisconsin - Uniform Prior Authorization Form
Benefits investigation
Reimbursement help (FRM)
Gammagard Liquid Financial Assistance Options
Copay savings program
Learn More
Overview
- Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)
Patient benefit
- A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max
Patient eligibility
- Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
- Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
- May never be used with government insurance
How to sign up
- Cards may be downloadable digital cards or hard copies
- Some pharmacos offer debit cards with pre-loaded copay benefit
- Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
- Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form
Gammagard Liquid PubMed™ News
Gammagard Liquid Patient Education
To share resource; ask patient to:
1.Pull out phone
2.Open camera
3.Scan QR code with camera
4.Tap link
Patient toolkit
About Gammagard Liquid: Primary Immunodeficiency (PI)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Open Camera on Phone
Scan QR Code & Tap Link
Side Effects: Primary Immunodeficiency (PI)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Open Camera on Phone
Scan QR Code & Tap Link
Patient Resources: Primary Immunodeficiency (PI)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Open Camera on Phone
Scan QR Code & Tap Link
Patient Brochure: Primary Immunodeficiency (PI)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Open Camera on Phone
Scan QR Code & Tap Link
About Gammagard Liquid: Multifocal Motor Neuropathy (MMN)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Open Camera on Phone
Scan QR Code & Tap Link
Side Effects: Multifocal Motor Neuropathy (MMN)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Open Camera on Phone
Scan QR Code & Tap Link
Doctor Discussion Guide: Multifocal Motor Neuropathy (MMN)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Open Camera on Phone
Scan QR Code & Tap Link
Patient Resources: Multifocal Motor Neuropathy (MMN)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Open Camera on Phone
Scan QR Code & Tap Link
Patient Brochure: Multifocal Motor Neuropathy (MMN)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Open Camera on Phone
Scan QR Code & Tap Link
Gammagard Liquid FAQs
Gammagard is available in 6 dosages, including 100 mg/ml Injection 10 ml, 100 mg/ml Injection 100 ml, 100 mg/ml Injection 200 ml, 100 mg/ml Injection 25 ml, 100 mg/ml Injection 300 ml and 100 mg/ml Injection 50 ml
Gammagard treats Immunologic Deficiency Syndromes
Gammagard contains immunoglobulin G which is a Human Immunoglobulin G
Gammagard is administered as a Injectable
Gammagard mechanism of action is Antigen Neutralization
We receive information directly from the FDA and PrescriberPoint is updated as frequently as change are made available